SR-13668

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSR-13668
Drug Alias NameSR-13668
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitors
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSri InternationalNational Cancer InstituteBridge Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBridge PharmaNational Cancer InstituteSri International
Active IndicationsN/A
Inactive IndicationsLymphoma

Other Information

ATC CodeN/A
Related LinksN/A